删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Genome transfer for the prevention of female infertility caused by maternal gene mutation

本站小编 Free考研考试/2022-01-01

Dandan Baia, 1,
Jin Suna, 1,
Yanping Jiaa, 1,
Jiqing Yina,
Yalin Zhanga,
Yanhe Lia,
Rui Gaoa,
Xiling Dua,
Kunming Lia,
Jiaming Lina,
Zhifen Tua,
Yu Wanga,
Jiaping Pana,
Shanshan Lianga,
Yi Guoa,
Jingling Ruana,
Xiaochen Koua,
Yanhong Zhaoa,
Hong Wanga,
Cizhong Jianga,
Fengchao Wangb,
Xiaoming Tenga,
Wenqiang Liua,
Shaorong Gaoa
aClinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China
bNational Institute of Biological Sciences, NIBS, Beijing, 102206, China

More InformationCorresponding author: E-mail address: tengxiaoming@51mch.com (Xiaoming Teng);E-mail address: liuwenqiang@tongji.edu.cn (Wenqiang Liu);E-mail address: gaoshaorong@tongji.edu.cn (Shaorong Gao)
Publish Date:2020-06-25




Abstract
Poor oocyte quality is associated with early embryo developmental arrest and infertility. Maternal gene plays crucial roles in the regulation of oocyte maturation, and its mutation is a common cause of female infertility. However, how to improve oocyte quality and develop effective therapy for maternal gene mutation remains elusive. Here, we use Zar1 as an example to assess the feasibility of genome transfer to cure maternal gene mutation–caused female infertility. We first discover that cytoplasmic deficiency primarily leads to Zar1-null embryo developmental arrest by disturbing maternal transcript degradation and minor zygotic genome activation (ZGA) during the maternal-zygotic transition. We next perform genome transfer at the oocyte (spindle transfer or polar body transfer) and zygote (early pronuclear transfer or late pronuclear transfer) stages to validate the feasibility of preventing Zar1 mutation–caused infertility. We finally demonstrate that genome transfer either at the oocyte or at the early pronuclear stage can support normal preimplantation embryo development and produce live offspring. Moreover, those pups grow to adulthood and show normal fertility. Therefore, our findings provide an effective basis of therapies for the treatment of female infertility caused by maternal gene mutation.
Keywords: Infertility,
Oocytes,
Maternal-zygotic transition,
ZGA,
Spindle transfer,
Genome transfer



PDF全文下载地址:

http://www.jgenetgenomics.org/article/exportPdf?id=1aba07ad-0cb8-40bb-a599-37c63ba72d0a&language=en
相关话题/Genome transfer prevention